Cargando…
Preferences for health outcomes associated with Group A Streptococcal disease and vaccination
BACKGROUND: A 26-valent Group A Streptococcus (GAS) vaccine candidate has been developed that may provide protection against pharyngitis, invasive disease and rheumatic fever. However, recommendations for the use of a new vaccine must be informed by a range of considerations, including parents'...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848145/ https://www.ncbi.nlm.nih.gov/pubmed/20226042 http://dx.doi.org/10.1186/1477-7525-8-28 |